BLEPHAMIDE is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Sulfacetamide Sodium; Prednisolone Acetate.
| Product ID | 11980-022_01643437-7cdb-4f32-bb3e-8be326b99127 | 
| NDC | 11980-022 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | BLEPHAMIDE | 
| Generic Name | Sulfacetamide Sodium And Prednisolone Acetate | 
| Dosage Form | Suspension/ Drops | 
| Route of Administration | OPHTHALMIC | 
| Marketing Start Date | 1961-10-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA012813 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | SULFACETAMIDE SODIUM; PREDNISOLONE ACETATE | 
| Active Ingredient Strength | 100 mg/mL; mg/mL | 
| Pharm Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 1961-10-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA012813 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 1961-10-01 | 
| Marketing Category | NDA | 
| Application Number | NDA012813 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 1961-10-01 | 
| Marketing Category | NDA | 
| Application Number | NDA012813 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-10-29 | 
| Marketing End Date | 2012-01-18 | 
| Ingredient | Strength | 
|---|---|
| SULFACETAMIDE SODIUM | 100 mg/mL | 
| SPL SET ID: | 0e5644af-2a3c-493a-bc24-174e5f36235b | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0023-0313 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate | 
| 11980-022 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  BLEPHAMIDE  72119340  0724725 Live/Registered | Allergan Pharmaceuticals, Inc. 1961-05-05 |